0001237899-21-000018.txt : 20210824 0001237899-21-000018.hdr.sgml : 20210824 20210824160603 ACCESSION NUMBER: 0001237899-21-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210820 FILED AS OF DATE: 20210824 DATE AS OF CHANGE: 20210824 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAROSA JOSEPH J CENTRAL INDEX KEY: 0001238303 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 211202266 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-08-20 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001238303 LAROSA JOSEPH J 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP General Counsel and Secret Common Stock 2021-08-20 4 M 0 10000 179.13 A 23182 D Common Stock 2021-08-20 4 F 0 6575 664.85 D 16607 D Common Stock 2021-08-23 4 S 0 3383 661.8 D 13224 D Common Stock 2021-08-23 4 S 0 41 665.4 D 13183 D Common Stock 2021-08-23 4 S 0 1 666.22 D 13182 D Common Stock 3186 I 2021 GRAT Common Stock 314 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 179.13 2021-08-20 4 M 0 10000 0.0 D 2022-12-14 Common Stock 10000 30000 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 41 shares of Company stock on August 23, 2021 at prices ranging from $665.21 to $665.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Joseph LaRosa 2021-08-23